Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$474,788
-$4,631,759 QoQ
Shares Held
8,240
-90.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,574
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STANCE CAPITAL LLC holds $17,488,887 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
13,480 | $4,881,377 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
36,089 | $4,559,483 | |
| 3 | ABBV |
AbbVie Inc.
|
7,664 | $1,928,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,779 | $1,899,101 | |
| 5 | PFE |
Pfizer Inc
|
78,762 | $1,896,588 | |
| 6 | LLY |
ELI LILLY & Co
|
1,530 | $1,835,128 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
8,240 | $474,788 | |
| 8 | NVO |
Novo Nordisk A S
|
289 | $13,854 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,788 | 8,240 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,106,547 | 84,197 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,472,669 | 27,302 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $1,578,093 | 34,991 | Shares | Defined | 2025-11-19 | |
| 2025-06-30 | $1,536,596 | 33,195 | Shares | Defined | 2025-08-22 | |
| 2025-03-31 | $2,583,840 | 42,365 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $180,992 | 3,200 | Shares | Defined | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||